Clinical Trials Logo
  1. Home
  2. Misoprostol
  3. NCT03140384

Compare the Different Routes of Administration of Misoprostol During Medicinal Abortion Between 7 and 9 Weeks of Amenorrhoea (SA) — Misoprostol  

Misoprostol Clinical Trial

Official title:
Compare the Different Routes of Administration of Misoprostol During Medicinal Abortion Between 7 and 9 Weeks of Amenorrhoea (SA)

Clinical Trial Summary

In France, drug-induced abortion is allowed up to 9SA, after which the surgical route is preferred. Mifepristone 600mg is used 36-48 hours before the introduction of Misoprostol. This is recommended orally at a dose of 400 μg. There are currently several studies on the subject, including a meta-analysis of the 2011 Cochrane Database, but doses, routes of administration and gestational age differ in all studies. Currently, HAS recommends the vaginal route at the dose of 800μg for stopped pregnancies. It is therefore necessary to compare the different routes of administration of Misoprostol at the same dose to allow to change our French recommendations on the medicinal abortion and perhaps also to recommend the vaginal route in this indication.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03140384
Study type Interventional
Source Centre Hospitalier Universitaire, Amiens
Contact
Status Withdrawn
Phase Phase 3
Start date August 20, 2017
Completion date July 20, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT04604366 - Comparison of Vaginal Versus Sublingual Misoprostol in the Treatment of First Trimester Missed Miscarriage Phase 2
Completed NCT03727308 - Study of Clinic-based Versus Self-use of Medical Abortion Pills
Completed NCT00426491 - Misoprostol for Non-Viable Pregnancies Phase 3
Recruiting NCT03106389 - Misoprostol With And Without Transcervical Balloon Catheter In Second Trimester Termination Of Pregnancy Phase 4
Not yet recruiting NCT05343546 - Ideal Timing of Intrauterine Contraception Insertion After Medical Management of First Trimester Incomplete Abortion N/A
Recruiting NCT01636063 - Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks N/A
Not yet recruiting NCT05696574 - Oral and Vaginal Misoprostol for Induction of Labor in Nulliparous Pregnant Women N/A
Completed NCT04635007 - Tranexamic Acid Versus Misoprostol in Reducing Blood Loss in Cesarean Section in Primigravida Phase 3
Completed NCT04492072 - Misoprostol With Mechanical Dilation Versus Oxytocin With Mechanical Dilation for High-risk Pregnancy Inductions N/A
Not yet recruiting NCT05079061 - A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery Phase 4